Insider · CIK 0001283518

Frost Gregory Ian

Reports to the SEC for 2 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001283518

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2015-05-28	PGENPRECIGEN, INC. · Option to Purchase Common Stock (Right to Buy)M Exercise/Conversion	SVP--Health Sector	MExercise/Conversion	−200K sh	—	—	800,000
2015-05-28	PGENPRECIGEN, INC.M Exercise/Conversion	SVP--Health Sector	MExercise/Conversion	+200K sh	$22.77	+$4.55M	300,000
2014-03-04	PGENPRECIGEN, INC.P Purchase	SVP--Health Sector	PPurchase	+58K sh	$26.04	+$1.51M	100,000
2014-03-03	PGENPRECIGEN, INC.P Purchase	SVP--Health Sector	PPurchase	+3,500 sh	$24.59	+$86.1K	42,000
2014-02-28	PGENPRECIGEN, INC.P Purchase	SVP--Health Sector	PPurchase	+38.5K sh	$25.93	+$998K	38,500
2014-01-06	PGENPRECIGEN, INC. · Option to Purchase Common StockA Award	SVP--Health Sector	AAward	+1M sh	—	—	1,000,000
2013-12-11	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	Director, CEO, President	MExercise/Conversion	+10.4K sh	$2.02	+$21K	3,601,800
2013-12-11	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common Stock (ISO)M Exercise/Conversion	Director, CEO, President	MExercise/Conversion	−6,467 sh	—	—	0
2013-12-11	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	Director, CEO, President	MExercise/Conversion	+33.1K sh	$2.05	+$67.9K	3,641,380
2013-12-11	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	Director, CEO, President	MExercise/Conversion	+6,467 sh	$2.02	+$13.1K	3,608,267
2013-12-11	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common Stock (ISO)M Exercise/Conversion	Director, CEO, President	MExercise/Conversion	−33.1K sh	—	—	667
2013-12-11	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common Stock (NSO)M Exercise/Conversion	Director, CEO, President	MExercise/Conversion	−10.4K sh	—	—	34,864
2013-08-12	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockM Exercise/Conversion	Director, CEO, President	MExercise/Conversion	−20K sh	$2.05	−$41K	40,000
2013-08-12	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	Director, CEO, President	MExercise/Conversion	+20K sh	$2.05	+$41K	3,591,380
2013-02-04	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockA Award	Director, CEO, President	AAward	+65K sh	$6.55	+$426K	65,000
2013-02-04	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsA Award	Director, CEO, President	AAward	+39K sh	—	—	39,000
2013-02-02	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	Director, CEO, President	MExercise/Conversion	+4,737 sh	—	—	3,571,380
2013-02-02	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	Director, CEO, President	MExercise/Conversion	+11.3K sh	—	—	3,566,643
2012-08-13	HALOHALOZYME THERAPEUTICS, INC.P Purchase	Director, CEO, President	PPurchase	+2,000 sh	$5.50	+$11K	3,555,331
2012-05-15	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	Director, CEO, President	MExercise/Conversion	+16.5K sh	—	—	3,553,331
2012-02-02	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsA Award	Director, CEO, President	AAward	+30K sh	—	—	30,000
2012-02-02	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockA Award	Director, CEO, President	AAward	+60K sh	$11.29	+$677K	60,000
2012-02-02	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsA Award	Director, CEO, President	AAward	+96.1K sh	—	—	96,065
2011-08-09	HALOHALOZYME THERAPEUTICS, INC.P Purchase	Director, CEO, President	PPurchase	+6,000 sh	$5.84	+$35K	3,536,866
2011-05-10	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsA Award	Director, CEO, President	AAward	+26K sh	—	—	26,000
2011-05-05	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockA Award	Director, CEO, President	AAward	+2,000 sh	$6.21	+$12.4K	2,000
2010-02-04	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common Stock (ISO)A Award	Director, CEO, President	AAward	+17.7K sh	$5.55	+$98.2K	17,687
2010-02-04	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common Stock (NSO)A Award	Director, CEO, President	AAward	+62.3K sh	$5.55	+$346K	62,313
2009-02-05	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockA Award	Director, CEO, President	AAward	+80K sh	$6.10	+$488K	257,480
2007-06-12	HALOHALOZYME THERAPEUTICS, INC. · Options to Purchase Common StockM Exercise/Conversion	Director, CEO, President	MExercise/Conversion	−20.9K sh	$0.43	−$8,985.28	1,152,483
2007-06-12	HALOHALOZYME THERAPEUTICS, INC.F Tax Payment	Director, CEO, President	FTax Payment	−896 sh	$10.02	−$8,977.92	2,929,606
2007-06-12	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	Director, CEO, President	MExercise/Conversion	+22.2K sh	$0.45	+$9,999.554	2,930,502
2007-06-12	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	Director, CEO, President	MExercise/Conversion	+20.9K sh	$0.43	+$8,985.28	2,908,261
2007-06-12	HALOHALOZYME THERAPEUTICS, INC. · WarrantM Exercise/Conversion	Director, CEO, President	MExercise/Conversion	−22.2K sh	$0.45	−$9,999.554	1,130,242
2007-06-07	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, CEO, President	SSale	−1,000 sh	$10.53	−$10.5K	2,078,065
2007-06-07	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, CEO, President	SSale	−600 sh	$10.32	−$6,192	2,905,665
2007-06-07	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, CEO, President	SSale	−600 sh	$10.54	−$6,324	2,077,465
2007-06-07	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, CEO, President	SSale	−500 sh	$10.31	−$5,155	2,906,265
2007-06-07	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, CEO, President	SSale	−3,500 sh	$10.52	−$36.8K	2,079,065
2007-06-07	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, CEO, President	SSale	−100 sh	$10.55	−$1,055	2,077,365
2007-06-07	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, CEO, President	SSale	−500 sh	$10.31	−$5,155	2,096,265
2007-06-07	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, CEO, President	SSale	−600 sh	$10.30	−$6,180	2,096,765
2007-06-07	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, CEO, President	SSale	−600 sh	$10.30	−$6,180	2,906,765
2007-06-07	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, CEO, President	SSale	−1,900 sh	$10.49	−$19.9K	2,090,065
2007-06-07	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	Director, CEO, President	MExercise/Conversion	+20.9K sh	$0.43	+$8,966.79	2,098,218
2007-06-07	HALOHALOZYME THERAPEUTICS, INC.F Tax Payment	Director, CEO, President	FTax Payment	−853 sh	$10.51	−$8,965.03	2,907,365
2007-06-07	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, CEO, President	SSale	−6,200 sh	$10.50	−$65.1K	2,083,865
2007-06-07	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director, CEO, President	SSale	−1,300 sh	$10.51	−$13.7K	2,082,565
2007-06-07	HALOHALOZYME THERAPEUTICS, INC.F Tax Payment	Director, CEO, President	FTax Payment	−853 sh	$10.51	−$8,965.03	2,097,365
2007-06-07	HALOHALOZYME THERAPEUTICS, INC. · Options to Purchase Common StockM Exercise/Conversion	Director, CEO, President	MExercise/Conversion	−20.9K sh	$0.43	−$8,966.79	1,173,379

Recent filings

Accepted (ET)
Jun 14
INTREXON CORP0001356090-15-000031
SEC(opens sec.gov)
Mar 44
INTREXON CORP0001498902-14-000023
SEC(opens sec.gov)
Jan 84
INTREXON CORP0001498902-14-000005
SEC(opens sec.gov)
Dec 114
HALOZYME THERAPEUTICS INC0001483813-13-000101
SEC(opens sec.gov)
Aug 144
HALOZYME THERAPEUTICS INC0001209191-13-040761
SEC(opens sec.gov)
Feb 64
Frost Gregory Ian0001483813-13-000022
SEC(opens sec.gov)
Feb 54
Frost Gregory Ian0001483813-13-000015
SEC(opens sec.gov)
Aug 144
Frost Gregory Ian0001483813-12-000026
SEC(opens sec.gov)
May 174
Frost Gregory Ian0001483813-12-000023
SEC(opens sec.gov)

Companies

Address

C/O HALOZYME THERAPEUTICS, INC. 11388 SORRENTO VALLEY ROAD

SAN DIEGO, CA, 92121